The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. While CBN is often marketed as “the sleep cannabinoid ,” the reality is more complicated.

Sleep 137

Sleep Data Tincture Research and Development 137

The Cannigma

NOVEMBER 12, 2023

The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.

Data 126

Data Tincture Research and Development Food 126

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. EG: Right, yeah.

Data 127

Data Research and Development Patients Strains 127

Project CBD

MAY 17, 2016

New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.

CBD 185

CBD Data Cannabinoids THC 185

Project CBD

JANUARY 24, 2019

Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Cannabinoid crystals. Across political boundaries, a group of scientists from Russia, China, and the USA crystallized the CB2 cannabinoid receptor.

Research and Development 258

Research and Development Chronic Pain Cannabinoids Treatment 258

The Cannigma

NOVEMBER 24, 2022

Here’s how it works: Fill out the screening questionnaire to see if you’re a good fit Week 1: screening week for approved participants (baseline data) Weeks 2 – 3: Consuming the product and sharing your experience with People Science. The data collected will be sent to People Science, along with the responses from a short daily questionnaire.

Sleep 105

Sleep Collective Data Tincture 105

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. An abstract of the study, “Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury,” is online here.

Clinical Trials 253

Clinical Trials THC Consumption Therapy 253

Green Relief

MAY 7, 2021

BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.

Data 98

Data Marijuana Chronic Pain Oil 98

Veriheal

SEPTEMBER 6, 2022

Synthetic cannabis and cannabinoids have been connected to adverse effects time and time again. When it comes to synthetic or semi-synthetic cannabinoids, consumers are often unaware of the potential risks that come with consuming such forms of cannabis. Examples of these are delta-8 THC , delta-10 THC , and HHC. .

Cannabinoids 98

Cannabinoids THC CBD Blood Pressure 98

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 208

Clinical Trials Chronic Pain Data Treatment 208

Project CBD

JUNE 20, 2023

The endocannabinoid system is widely distributed throughout the gastrointestinal system, including not only CB1 and CB2 cannabinoid receptors but also other cannabinoid targets like PPARs, GPR55, and TRPV1. Even small doses of cannabis can soothe the stomach and stimulate the appetite.

Cannabinoids 215

Cannabinoids Patients Treatment Conditions 215

Project CBD

MAY 17, 2016

New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.

CBD 146

CBD Data Cannabinoids THC 146

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. absorption), at least with rectal insertion.

Data 98

Data CBD Collective Cannabinoids 98

NORML

MARCH 20, 2019

NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events.

THC 280

THC Data Cannabis Events 280

NORML

SEPTEMBER 5, 2019

State regulators licensed farmers and researchers to cultivate over 500,000 total acres of industrial hemp in the first half of 2019, according to data compiled by the organization VoteHemp.com. percent THC) and products containing cannabinoids derived from hemp from the federal Controlled Substances Act.

Hemp 37

Hemp Agriculture Cultivation Data 37

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 216

Cannabinoids Sleep Clinical Trials CBD 216

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

AUGUST 23, 2021

Oxford Cannabinoid Technologies Holdings plc. After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Pre-Close Trading Update; US OTC QB Market Application. &

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Cannabis Law Report

NOVEMBER 12, 2021

Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Project CBD

FEBRUARY 27, 2023

Across the eight studies they analyzed, the Australia-based authors identified increased levels of oleoylethanolamide and stearoylethanolamide (endocannabinoid-like molecules called N-Acylethanolamines that don’t bind with the cannabinoid receptors) in patients with these conditions compared to controls. Pain reports vol. 7,6 e1045.

THC 144

THC CBD Clinical Trials Sleep 144

The Cannigma

NOVEMBER 1, 2023

Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains.

Topical 105

Topical Data Cannabinoids Terpenes 105

The Cannigma

FEBRUARY 28, 2021

“But we can assure them with good information about how their symptoms may improve and how their quality of life may improve with cannabinoid formulations and drugs.”. That understanding is only one of the major shifts happening in medicine with regards to cannabis and cannabinoid research. seventyfour74/123rf). Shutterstock).

Treatment 145

Treatment Cannabinoids Hash Patients 145

MedicalJane

JUNE 12, 2020

The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Cheri

APRIL 1, 2022

We know that cannabinoids like THC and CBD are fat soluable. In other words, ketogenesis seemed to increase the responsiveness of the ECS and the overall number of cannabinoid receptors within the intestines. Cannabinoids and their metabolites are stored primarily in fat cells. Read more here. It’s really a match made in heaven.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Cannabis Chronicles

JANUARY 30, 2019

— writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. Not everyone in the field of cannabis and cannabinoid research was put off by the articles. In 2017, for example, Washington had 304.5

Marijuana 124

Marijuana Data Cannabinoids Medicine 124

The Cannigma

DECEMBER 20, 2021

Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Since then, numerous studies have explored cannabinoid activity in the different skin layers.

Terpenes 145

Terpenes Cannabinoids Topical Research and Development 145

FloridaMarijuana.net

SEPTEMBER 24, 2018

The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.” When terpenes and cannabinoids interact together, there is a heightened efficacy for medical marijuana patients. They termed this the “Entourage Effect.” Dogwalker OG.

Terpenes 162

Terpenes Oil Strains Research and Development 162

The Cannigma

MAY 28, 2021

When you smoke cannabis, the cannabinoids enter the bloodstream through your lungs and throat, while edibles are metabolized inside the gut. Topical solutions can activate the cannabinoid receptors in the epidermis, but they do not penetrate deeply into the skin, so they’re most effective for localized treatment.

Topical 140

Topical Oil Cannabinoids Cannabis 140

The Cannigma

OCTOBER 21, 2021

More than likely, the effects of cannabinoids like CBD and THC are altered during the ketogenic diet, but unfortunately there has been very little research on this topic. This would hypothetically correlate with the altered effects of cannabinoids like THC and CBD, but the study did not look at that. As per usual, more data is needed.

Cannabinoids 145

Cannabinoids Edibles Conditions Data 145

Veriheal

FEBRUARY 28, 2023

Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. million, People Science plans to invest in ongoing R&D on cannabis, cannabinoids, the microbiome, psychedelics, and digital health interventions. The company is now sitting on $8.5

Sleep 52

Sleep Cannabinoids Data Food 52

The Cannigma

FEBRUARY 16, 2021

They require a process in which THC or other cannabinoid particles are reduced to nanoscopic size that allows them to then be mixed with water or other aqueous liquids. There is not extensive safety data available, however. The nanoemulsion method ALT uses is effective for all cannabinoids, not only THC, he said. Shutterstock).

Edibles 140

Edibles Digestion Tincture Cannabinoids 140

NORML

AUGUST 26, 2019

We had lawmakers who were just proposing lists of diseases that they felt were deserving, and we tried very narrow approaches, proposing two diseases, cancer and Crohn’s disease specifically, and we were being met with questions like, “Where are the data on that?” ” We later lowered the minimum cannabinoid requirement.

Marijuana 235

Marijuana Legalization Programs Oil 235

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr presents an emulsion-based drug delivery system tailored for cannabinoids and made to tackle America’s diabetes crisis.

Research and Development 110

Research and Development Consumption Education Data 110

Cannabis Law Report

JUNE 25, 2021

Use of Non-controlled Cannabinoids in Food. The federal Cannabis Act and the regulations enacted thereunder contain extensive provisions relating to how cannabinoids can be incorporated into food and other products. Originally Published by Chambers Medical Cannabis & Cannabinoid Regulation 2021 Global Practice Guide.

Cannabinoids 70

Cannabinoids Edibles Retail Cannabis 70

The Cannigma

FEBRUARY 2, 2021

“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 107

Patients Clinical Trials Research and Development Treatment 107